Search for: "Merck & Co. v. TEVA PHARMACEUTICALS USA"
Results 1 - 20
of 33
Sorted by Relevance
|
Sort by Date
25 Aug 2008, 4:10 am
STMicroelectronics, Inc., Teva Pharmaceuticals USA, Inc. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
4 Sep 2009, 12:11 pm
(quoting Merck & Co. v. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
6 Apr 2017, 1:35 pm
Teva Pharms. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
29 Aug 2012, 10:09 pm
In a December 2011 Complaint, several direct purchasers allege that Wyeth, acting alone and/or in concert with first generic applicant Teva Pharmaceuticals USA, Inc. [read post]
6 Apr 2011, 12:18 am
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) –… [read post]
11 Dec 2013, 7:55 pm
” Merck & Co. v. [read post]
6 Nov 2015, 6:58 am
This is actually presaged in Teva UK Ltd v Merck & Co Inc [2009] EWHC 2952 (Pat), although in that case the issue did not actually arise.Inventive stepThe inventive step argument was essentially – gabapentin is similar to pregabalin, gabapentin is known for the treatment of pain, so it is obvious that pregabalin would also be effective to treat pain. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
9 Apr 2019, 8:03 pm
Teva Pharmaceuticals USA, Inc., 395 F.3d 1364 (Fed. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
12 Dec 2008, 8:42 am
See Merck & Co. v. [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
23 Nov 2007, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalReputation and privacy in the online social media world: (IPWar's), McAfee typosquatting study results and implications: (IPWar's),Larry Lessig's comments on how creativity is being strangled by the law: (BLOG@IP::JUR)Two interesting papers on Creative Commons: (CreativeCommons)Friction and 'Warfighting': (IP Think Tank),More on the controversy at WIPO over Kamil Idris'… [read post]
